优化吸烟者组织扩张器乳房再造:一种算法化方法
该回顾性研究评估吸烟者组织扩张器乳房再造的改良策略:乳房切除后至少延迟7天再重建并将扩张器置于肌下(Group I),与标准即刻重建的吸烟者(Group II)和非吸烟者(Group III)比较。Group I伤口裂开1/19,与Group III的18/285无显著差异(p=1.0);Group II伤口裂开6/19,显著多于Group III(p=0.002)。
要点
- 吸烟者延迟≥7天且肌下放置扩张器,伤口裂开风险与非吸烟者标准重建无显著差异(p=1.0)。
- 吸烟者即刻重建伤口裂开6/19,显著高于非吸烟者的18/285(p=0.002)。
- 非吸烟者中胸前放置与肌下放置伤口裂开无显著差异(7.0% vs 4.8%,p=0.60)。
核心结论
- 吸烟者若在乳房切除后至少7天(允许血管延迟和分界)行组织扩张器乳房再造并将扩张器置于肌下,可将皮肤坏死风险 normalized 至与非吸烟者标准重建相当。
研究设计与样本
- 回顾性研究,共195例患者(323侧乳房再造):Group I(10例,19个扩张器)、Group II(11例,19个扩张器)、Group III(174例,285个扩张器)。
主要发现
- Group I伤口裂开需手术处理1/19侧乳房,Group III为18/285侧(p=1.0)。
- Group II伤口裂开6/19侧,多于Group III的18/285侧(p=0.002)。
- Group III中胸前放置扩张器伤口裂开7.0%,肌下放置4.8%,无显著差异(p=0.60)。
临床怎么用
- 作者提出的策略为:吸烟者在乳房切除后至少7天行组织扩张器再造,并将扩张器置于肌下。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Smoking is a risk factor for post-operative complications following breast reconstruction. Abruptly refraining from all nicotine products may be difficult for patients with a new cancer diagnosis. The goal of this study is to assess complications following a distinct approach to tissue expander reconstruction in nicotine users. METHODS: Patients who underwent tissue expander reconstruction after mastectomy were retrospectively reviewed. The approach to optimize outcomes in smokers was to delay reconstruction at least 7 days after the mastectomy and place the expander submuscularly (Group I). The other patients underwent standard immediate reconstruction on the day of mastectomy and were divided into Group II (active smokers) and Group III (non-smokers). Group III was considered the control group. RESULTS: There was a total of 195 patients (323 breast reconstructions): Group I (10 patients, 19 expanders); Group II (11 patients, 19 expanders) and Group III (174 patients, 285 expanders). In Group I, n = 1/19 breasts had wound dehiscence requiring surgical management, compared to n = 18/285 in Group III (p = 1.0). Group II exhibited more wound dehiscence (n = 6/19) compared to Group III (p = 0.002). There was no significant difference when comparing wound dehiscence in prepectoral expander placement (7.0%) versus submuscular placement (4.8%) in Group III (p = 0.60). CONCLUSION: Nicotine users who are offered tissue expander breast reconstruction 1) at least 7 days after the mastectomy (to allow for vascular delay and demarcation) and 2) in the submuscular plane can normalize their risk of skin necrosis to that of non-smokers who have standard (prepectoral or submuscular) reconstruction on the day of mastectomy.
引用
- Dawson SE, Berns JM, Tran PC, et al. Optimizing tissue expander breast reconstruction in nicotine users: An algorithmic approach. J Plast Reconstr Aesthet Surg. 2022. PMID: 35842287. doi:10.1016/j.bjps.2022.06.080
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。